FDA Restructuring Continues with Departure of Top Drug Regulator
· Telemundo McAllen (KTLM)
Dr. Tracy Beth Hoeg, who oversaw drug safety evaluations at the FDA, has been removed from her position as interim director of the agency's drug center. She will be succeeded by Dr. Mike Davis, the former deputy director. Hoeg announced her dismissal on social media, stating she leaves without regrets. This change is part of a broader restructuring at the FDA, which has seen other high-profile resignations, including Commissioner Marty Makary. Hoeg's tenure was marked by her involvement in controversial topics such as COVID-19 vaccines and antidepressant safety, reflecting her alignment with certain political figures and her previous criticisms of public health measures during the pandemic.
AI summary · Source: Telemundo McAllen (KTLM) →
